Literature DB >> 1133649

Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis.

E H Oppenheimer, J R Esterly.   

Abstract

Focal biliary cirrhosis is an uncommon finding in infants with cystic fibrosis, but it is present in more than a fifth of surviving children and adolescents. It was found at postmortem examination in only five of 47 infants with CF younger than 3 months, in five of 32 infants from 3 to 12 months, and in 18 of 67 children older than 1 year. In infants under 3 months, excessive mucus in intrahepatic bile ducts was seen in 11 necropsies; in 15 others there were only nonspecific periportal changes. Cholestasis was found in the livers of 18 of the 26 infants. Excessive mucus in the biliary tree was occasionally associated with periportal changes and cholestasis in older infants. The periportal changes, which are regarded as nonspecific, were never found in infants more than 1 year of age.

Entities:  

Mesh:

Year:  1975        PMID: 1133649     DOI: 10.1016/s0022-3476(75)80351-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Prevalence of liver disease in cystic fibrosis.

Authors:  R Scott-Jupp; M Lama; M S Tanner
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

3.  Pathophysiological preconditions promoting mixed "black" pigment plus cholesterol gallstones in a DeltaF508 mouse model of cystic fibrosis.

Authors:  Folke Freudenberg; Monika R Leonard; Shou-An Liu; Jonathan N Glickman; Martin C Carey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

Review 4.  Current clinical management of hepatic problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

5.  An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer.

Authors:  Y Yang; S E Raper; J A Cohn; J F Engelhardt; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

6.  Immunoassay of serum conjugates of cholic acid in cystic fibrosis.

Authors:  G P Davidson; M Corey; F Morad-Hassel; J M Sondheimer; D Crozier; G G Forstner
Journal:  J Clin Pathol       Date:  1980-04       Impact factor: 3.411

7.  Neonatal cholestasis as the presenting feature in cystic fibrosis.

Authors:  P Lykavieris; O Bernard; M Hadchouel
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

8.  Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.

Authors:  T A Robb; G P Davidson; C Kirubakaran
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

9.  Hepatobiliary sonography in cystic fibrosis.

Authors:  S P Quillin; M J Siegel; R Rothbaum
Journal:  Pediatr Radiol       Date:  1993

10.  Development of a porcine model of cystic fibrosis.

Authors:  Michael J Welsh; Christopher S Rogers; David A Stoltz; David K Meyerholz; Randall S Prather
Journal:  Trans Am Clin Climatol Assoc       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.